[1]
B. Salustio Pires, J. Bratke, J. do Nascimento Santos Costa, M. de Souza Nars, e M. F. Mussolino, “Access to the population, financing and availability times of antineoplastic drugs incorporated into the SUS between 2012 and 2024”, JAFF, vol. 10, nº 2, nov. 2025.